文献速递白血病

急性髓系白血病中的去甲基化表型

Demethylator phenotypes in acute myeloid leukemia.
PubMed 文献 · Leukemia · 2018-03-07

研究利用癌症基因组图谱194例急性髓系白血病(AML)患者的Illumina 450k芯片数据,通过层次聚类鉴定出两种去甲基化表型DMP.1和DMP.2;DMP.1富集NPM1、FLT3和DNMT3A突变,DMP.2包含t(8;21)、inv(16)或t(15;17)患者;整合额外236例独立数据验证后,DMP状态对预后有独立于年龄和细胞遗传学的影响。

要点

  • 层次聚类鉴定出DMP.1与DMP.2两种去甲基化表型。
  • DMP.1中NPM1突变占94%、FLT3占71%、DNMT3A占61%。
  • DMP状态对预后有独立于年龄和细胞遗传学的影响。

核心结论

  • AML中存在两种不同的去甲基化表型DMP.1和DMP.2,DMP状态对预后有独立于年龄和细胞遗传学的影响,可能增强现有风险分层工具。

研究设计与样本

  • 利用癌症基因组图谱194例AML患者的Illumina 450k芯片数据进行层次聚类,并整合额外236例独立450k数据集进行验证。

主要发现

  • DMP.1患者中NPM1突变占94%、FLT3突变占71%、DNMT3A突变占61%。
  • DNMT3A突变患者中仅40%为DMP.1。
  • DMP.2 AML由t(8;21)、inv(16)或t(15;17)患者组成。
  • RNA-seq显示DMP.1中免疫应答相关基因上调,DMP.2中发育相关基因上调。
  • 整合额外236例独立数据验证上述发现,并发现DMP状态对预后有独立于年龄和细胞遗传学的影响。

关键数值与推荐

  • DMP.1定义:层次聚类鉴定的去甲基化表型1,NPM1突变94%、FLT3突变71%、DNMT3A突变61%。
  • DMP.2定义:层次聚类鉴定的去甲基化表型2,包含t(8;21)、inv(16)或t(15;17)患者。
  • DNMT3A突变患者中仅40%归为DMP.1。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute myeloid leukemia (AML) often harbors mutations in epigenetic regulators, and also has frequent DNA hypermethylation, including the presence of CpG island methylator phenotypes (CIMPs). Although global hypomethylation is well known in cancer, the question of whether distinct demethylator phenotypes (DMPs) exist remains unanswered. Using Illumina 450k arrays for 194 patients from The Cancer Genome Atlas, we identified two distinct DMPs by hierarchical clustering: DMP.1 and DMP.2. DMP.1 cases harbored mutations in NPM1 (94%), FLT3 (71%) and DNMT3A (61%). Surprisingly, only 40% of patients with DNMT3A mutations were DMP.1, which has implications for mechanisms of transformation by this mutation. In contrast, DMP.2 AML was comprised of patients with t(8;21), inv(16) or t(15;17), suggesting common methylation defects connect these disparate rearrangements. RNA-seq revealed upregulated genes functioning in immune response (DMP.1) and development (DMP.2). We confirmed these findings by integrating independent 450k data sets (236 additional cases), and found prognostic effects by DMP status, independent of age and cytogenetics. The existence of DMPs has implications for AML pathogenesis and may augment existing tools in risk stratification.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Kelly AD, Madzo J, Madireddi P, et al. Demethylator phenotypes in acute myeloid leukemia. Leukemia. 2018. PMID: 29556023. doi:10.1038/s41375-018-0084-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。